Correction: Expansion of Cord Blood CD34+ Cells in Presence of zVADfmk and zLLYfmk Improved Their In Vitro Functionality and In Vivo Engraftment in NOD/SCID Mouse

Correction: Expansion of Cord Blood CD34+ Cells in Presence of zVADfmk and zLLYfmk Improved Their In Vitro Functionality and In Vivo Engraftment in NOD/SCID Mouse

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948919/?tool=EBI

Similar Items

Expansion of cord blood CD34 cells in presence of zVADfmk and zLLYfmk improved their in vitro functionality and in vivo engraftment in NOD/SCID mouse.
by: Sangeetha V M, et al.
Published: (2010-01-01)

Correction: Expansion of Cord Blood CD34 Cells in Presence of zVADfmk and zLLYfmk Improved Their In Vitro Functionality and In Vivo Engraftment in NOD/SCID Mouse.
Published: (2014-01-01)

Spiny mice (Acomys) cells fail to engraft in NOD scid gamma.
by: Janak Gaire, et al.
Published: (2023-01-01)

Genetic labelling of human bone marrow osteogenic stem cells: Differentiation potentials and engraftment into NOD/SCID mice.
by: Xia, Z, et al.
Published: (2001)

Human umbilical cord blood-derived CD34+ cells reverse osteoporosis in NOD/SCID mice by altering osteoblastic and osteoclastic activities.
by: Reeva Aggarwal, et al.
Published: (2012-01-01)

Human CD34+ CD133+ Hematopoietic Stem Cells Cultured with Growth Factors Including Angptl5 Efficiently Engraft Adult NOD-SCID Il2rγ−/− (NSG) Mice
by: Drake, Adam, et al.
Published: (2011)

Amniotic mesenchymal stem cells enhance wound healing in diabetic NOD/SCID mice through high angiogenic and engraftment capabilities.
by: Sung-Whan Kim, et al.
Published: (2012-01-01)

A radiolabeled antibody targeting CD123+ leukemia stem cells – initial radioimmunotherapy studies in NOD/SCID mice engrafted with primary human AML
by: Jeffrey V. Leyton, et al.
Published: (2015-01-01)

Correction: Amniotic Mesenchymal Stem Cells Enhance Wound Healing in Diabetic NOD/SCID Mice through High Angiogenic and Engraftment Capabilities
Published: (2012-01-01)

Correction: Amniotic Mesenchymal Stem Cells Enhance Wound Healing in Diabetic NOD/SCID Mice through High Angiogenic and Engraftment Capabilities.
by: Sung-Whan Kim, et al.
Published: (2012-01-01)

Correction: Amniotic Mesenchymal Stem Cells Enhance Wound Healing in Diabetic NOD/SCID Mice through High Angiogenic and Engraftment Capabilities
Published: (2012-01-01)

Correction: Amniotic Mesenchymal Stem Cells Enhance Wound Healing in Diabetic NOD/SCID Mice through High Angiogenic and Engraftment Capabilities
Published: (2012-01-01)

Correction: Amniotic Mesenchymal Stem Cells Enhance Wound Healing in Diabetic NOD/SCID Mice through High Angiogenic and Engraftment Capabilities.
by: Sung-Whan Kim, et al.
Published: (2012-01-01)

Correction: Amniotic Mesenchymal Stem Cells Enhance Wound Healing in Diabetic NOD/SCID Mice through High Angiogenic and Engraftment Capabilities.
by: Sung-Whan Kim, et al.
Published: (2012-01-01)

Blockade of Cd40-Cd154 Interferes with Human T cell Engraftment in Scid Mice
by: Teresa M. Foy, et al.
Published: (1998-01-01)

Umbilical cord blood CD34+ progenitor-derived NK cells efficiently kill ovarian cancer spheroids and intraperitoneal tumors in NOD/SCID/IL2Rgnull mice
by: Janneke S. Hoogstad-van Evert, et al.
Published: (2017-08-01)

Short-Term Culture with the Caspase Inhibitor z-VAD.fmk Reduces Beta Cell Apoptosis in Transplanted Islets and Improves the Metabolic Outcome of the Graft
by: Marta Montolio, et al.
Published: (2005-01-01)

Lack of tumorigenesis and protumorigenic activity of human umbilical cord mesenchymal stem cells in NOD SCID mice
by: Jie He, et al.
Published: (2022-03-01)

Inhibition of KSHV-associated lymphoma engraftment in SCID mouse by morpholino oligomers
by: Zhang Yanjin, et al.
Published: (2010-10-01)

Cochlear Repair by Transplantation of Human Cord Blood CD133+ Cells to Nod-Scid Mice Made Deaf with Kanamycin and Noise
by: Roberto P. Revoltella M.D., Ph.D., et al.
Published: (2008-06-01)

Improved function and proliferation of adult human beta cells engrafted in diabetic immunodeficient NOD-scid IL2rγnull mice treated with alogliptin
by: Jurczyk A, et al.
Published: (2013-12-01)

Long-term engraftment of human natural T regulatory cells in NOD/SCID IL2rγc(null) mice by expression of human IL-2.
by: Sojan Abraham, et al.
Published: (2012-01-01)

Induction of oxazolone-mediated features of atopic dermatitis in NOD-scid IL2Rγnull mice engrafted with human peripheral blood mononuclear cells
by: Thomas Nolte, et al.
Published: (2013-01-01)

Evaluating Human Immune Responses for Vaccine Development in a Novel Human Spleen Cell-Engrafted NOD-SCID-IL2rγNull Mouse Model
by: Stéphanie Ghosn, et al.
Published: (2018-03-01)

The Preconditioning of Busulfan Promotes Efficiency of Human CD133+ Cells Engraftment in NOD Shi-SCID IL2Rγcnull (NOG) Mice via Intra-Bone Marrow Injection
by: Xiaofang Guo, et al.
Published: (2019-07-01)

Differential post-surgical metastasis and survival in SCID, NOD-SCID and NOD-SCID-IL-2Rγ(null) mice with parental and subline variants of human breast cancer: implications for host defense mechanisms regulating metastasis.
by: Chloe C Milsom, et al.
Published: (2013-01-01)

Nonirradiated NOD,B6.SCID Il2rγ−/− KitW41/W41 (NBSGW) Mice Support Multilineage Engraftment of Human Hematopoietic Cells
by: Brian E. McIntosh, et al.
Published: (2015-02-01)

Increased Engraftment of Human Short Term Repopulating Hematopoietic Cells in NOD/SCID/IL2rγnull Mice by Lentiviral Expression of NUP98-HOXA10HD.
by: Allistair Abraham, et al.
Published: (2016-01-01)

Maintenance of Functional Human Cancellous Bone and Human Hematopoiesis in NOD/SCID Mice
by: Frédérique Hubin, et al.
Published: (2004-10-01)

Lixisenatide accelerates restoration of normoglycemia and improves human beta-cell function and survival in diabetic immunodeficient NOD–scid IL-2rgnull RIP-DTR mice engrafted with human islets
by: Yang C, et al.
Published: (2015-08-01)

NOD-scid IL2R γ<sup>null</sup> mice engrafted with human peripheral blood mononuclear cells as a model to test therapeutics targeting human signaling pathways
by: Zadeh-Khorasani Maryam, et al.
Published: (2013-01-01)

Human neural stem cells differentiate and promote locomotor recovery in an early chronic spinal cord injury NOD-scid mouse model.
by: Desirée L Salazar, et al.
Published: (2010-08-01)

Expansion of activated memory CD4+ T cells affects infectivity of CCR5-tropic HIV-1 in humanized NOD/SCID/JAK3null mice.
by: Kazutaka Terahara, et al.
Published: (2013-01-01)

Data in support of the bone analysis of NOD–SCID mice treated with zoledronic acid and prednisolone
by: Naoko Hori, et al.
Published: (2016-06-01)

Novel Engraftment and T Cell Differentiation of Human Hematopoietic Cells in ART−/−IL2RG−/Y SCID Pigs
by: Adeline N. Boettcher, et al.
Published: (2020-02-01)

Establishment of a Spontaneous Liver Fibrosis Model in NOD/SCID Mice Induced by Natural Aging
by: Lihua Qiu, et al.
Published: (2023-12-01)

The Assessment of Human Erythroid Output in NOD/SCID Mice Reconstituted with Human Hematopoietic Stem Cells
by: Jun Hayakawa, et al.
Published: (2010-11-01)

Fracture Healing Is Delayed in Immunodeficient NOD/scid‑IL2Rγcnull Mice.
by: Anna E Rapp, et al.
Published: (2016-01-01)

How to improve cord blood engraftment?
by: Meral eBeksac, et al.
Published: (2016-02-01)

Islet-specific CTL cloned from a type 1 diabetes patient cause beta-cell destruction after engraftment into HLA-A2 transgenic NOD/scid/IL2RG null mice.
by: Wendy W J Unger, et al.
Published: (2012-01-01)